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Summary
The macrophage mannose receptor is an integral membrane protein expressed on the surface
of tissue macrophages. After ligation ofmannose-rich glycoconjugates or pathogens, the receptor
mediates endorytosis and phagocytosis of the bound ligands by macrophages. The cDNAderived
primary structure of the mannose receptor predicts a cysteine-rich NH2-terminal domain, fol-
lowed by a fibronectin type II region. The remainder of the ectodomain is comprised of eight
carbohydrate recognition-like domains, followed by a transmembrane region, and a cytoplasmic
tail. Transfection of the mannose receptor cDNA into Cos-I cells is necessary for receptor-mediated
endorytosis of mannose-rich glycoconjugate as well as phagocytosis of yeasts. Deletion of the
cytoplasmic tail results in a mutant receptor that is able to bind but not ingest the ligated pathogens,
suggesting that the signal for phagocytosis is contained in the cytoplasmic tail.
P
lasma clearance and cell uptake experiments (1) indicated
the existence ofa receptor that bound glycoproteins bearing
high mannose chains. Receptor activity was especially evi-
dent in the liver and spleens, although most other tissues
were also positive. Subsequent experiments have established
that the mannose receptor is expressed on the cell surface of
tissue macrophages which reside in a wide anatomicaldistri-
bution throughout most organs (2). Although originally
defined by its ability to mediate endorytosis ofmannosylated
or fucosylated glycoproteins, the mannose receptor's predom-
inant role appears to be in host defense. The receptor en-
gages yeasts (3) and parasites (4) directly resulting in the en-
gulfment of these particles and the release ofbiologically active
secretory products like reactive oxygen intermediates (5),
arachidonate metabolites (6), neutral proteinases (7), and
monokines like IM and tumor necrosis factor (8) . As cir-
culating monocytes do not express the mannose receptor on
their cell surface (9), the functional role for the mannose
receptor appears to be on tissue macrophages, which in addi-
tion to their localization in the reticular endothelial system
line the alveolus and form a reticular network beneath epi-
thelial surfaces in the skin, the gastrointestinal tract, kidney,
and placenta (10). These sites are the portals of maximum
antigen load and underscore the role for the mannose receptor
in first line host defense.
Recent experiments suggest that a circulating hepatocyte-
derived serum mannose-binding protein is the functional serum
equivalent of the tissue macrophage mannose receptor. The
human mannose-binding protein (MBP)l is an acute-phase
reactant (11) that binds certain viruses (12) and other man-
nose rich pathogens (13). Mannose-binding proteins after
engaging organisms mediate attachment, uptake, and killing
of opsonized bacteria by circulating phagocytes that do not
express the mannose receptor (13). Underlying structural
similarity between the MBP and the mannose receptor, thereby
explaining their functional equivalence, was suggested by the
discovery that heteroantisera raised against human MBP were
able to immunoprecipitate a glycoprotein of 170 kD from
the surface of macrophages (Ezekowitz, R.A.B., and P. Stahl,
unpublished data), this being the molecular weight of the
macrophage mannose receptor (14) .
Based on these findings, it appeared likely that the man-
nose receptor is part of the same family of lectin-like proteins
as the mannose-binding protein that includes soluble pro-
teins and cell surface receptors, all of which share structural
homology in their carbohydrate recognition domains and re-
quire calcium for lgand binding (15) . Some of the cell sur-
face receptors in this group mediate endorytosis of glyco-
proteins with specific terminal residues exposed (15). The
functions of the lectin domains of more recent additions to
' Abbreviations used in thispaper. CRD, carbohydrate recognition domains;
MBP, mannose-binding protein; PGK, phosphoglycerate kinase.
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Mel14/Leu8 (16, 17), GMP140 (18), a granular membrane
protein of platelets and endothelium, and ELAM I (19), an
inducible endothelial antigen, have yet to be defined. The
mannosereceptor, like theasialoglycoprotein receptor family,
canrapidly recycle to the cell surface (1); however, the man-
nose receptor is the only member of this group of receptors
that can mediate phagocytosis.
The purification of the mannosereceptor from human and
rabbit macrophages and human placenta, an organ rich in
many cell types, including macrophages, yielded a 175-kD
glycoprotein that specifically bound a radiolabeled mannose-
BSAglycoconjugate (14, 20). Shared peptide information ob-
tained from mannosereceptor purified from human placenta
(as described in reference 21) enabled the characterization of
overlapping cDNAs that represent the human macrophage
mannose receptor as described in this study. In addition, we
show the macrophage expression of the mannose receptor
in Cos-I cells is necessary to mediate binding and phagocy-
tosis of mannoserich yeasts as well as pinocytosis of radiola-
beledmannosylated glycoconjugates. The cytoplasmic tail is
essential for phagocytosis, as a tailless mutant receptor fails
to induce ingestion of bound yeasts. The macrophage man-
nose receptor was found to be identical to the form from
placenta (21), suggesting that the cell of origin in placenta
may be the macrophage.
Materials and Methods
Isolation ofcDNAs.
￿
Sequences ofpeptides derived from human
placenta mannose receptor were shared andaredescribedpreviously
(21). Adegenerate oligonucleotide probewas synthesized on a oli-
gonucleotide synthesizer (DuPontCo., Wilmington, DE) purified
by gel filtration and labeled with (s2P]ATP and polynucleotide ki-
nase based on the peptide YVSWATGEPNFANED. Radiolabeled
probe was used to screen a pCDM8 placental cDNA library (gift
of Dr. B. Seed, Harvard Medical School, Boston, MA) by colony
hybridization. Four duplicate colonies were purified by two fur-
ther rounds of screening. Sequence analysis of all clones revealed
an exact match of encoded peptide. The insert from the largest
clone(3.3 kb) wasthen radiolabeled as described and used to screen
ahuman macrophage XGT11 cDNA library. This library waspre-
paredfrom poly(A) mRNA isolated from humanmonocytesculti-
vated for 7 d in Teflon beakers in thepresence of 10% autologous
human serum. These cultivated macrophages express 5 x 105
mannose receptors/cell. The cDNAs were constructed by a
modification (22) of the Okayama and Berg (23) method. The
cDNA pools were blunt-ended by treatmentwith T4 DNA poly-
merase and ligated to EcoRI linkers after protection of internal
EcoRI sites with Escherichia coli methylase. The linker-ligated
cDNAs were then digested with EcoRl and passed down a
Sepharose CL4B column and then ligated to phosphatase-treated
XGT11 vector DNA. The library contains 2 x 106recombinants
and wasplated on E. coli strain Y1088. Filters were prehybridized,
hybridized, andwashed as described(24). 25 positive phages were
isolated by two rounds ofamplification andanalyzed. In addition,
the library was screened with a 500-bp cDNA fragment which
contained the NH2-terminal portion of the receptor (a generous
gift from Drs. M. Taylor andK. Drickamer, Columbia University,
New York, NY) isolated from a placental cDNA library.
Sequential Strategy.
￿
The initial placental clone was sequenced
1786 Mannose Receptor-dependent Phagocytosis
by doubled-stranded sequencing using a modified T7 polymerase.
Sequenasewasbasedon theSanger et al. chain termination method
(25). Specific oligonucleotides were synthesized and used as se-
quencing primers. Forphage clones, 2 Al of purified stockwas an-
nealed to XGT11 primers from each ofthe arms, andthe Taq poly-
merase-amplified product obtained after 25 cycles (94°C, 30-s
denaturation, 55°C30-s annealing, and72°C3-min extension) on
athermalcycler (26) andthe products were gel purified by agarose
gelelectrophoresis. Thepurified products were digested with EcoRl
and subcloned into pUC-19 vector and the nucleotide sequenase
was determined as described above.
MannoseReceptorExpression.
￿
Afull-length clonewasconstructed
in CDM8 expression vector by a multiple step procedure. First,
aPCR product between 100 and 1,900 by was constructed using
asense5' primer containing an Xhol site andan antisense 3' primer
containing an EagI site using a 5' cloneas atemplate. Theproduct
wasdigested with Xhol andEagI and vectorally cloned into CDM8
digested with Xhol andNotl. Secondly, a3'3.3-kbclonewascloned
into the EcoRI site of CDM8 and clones of correct orientation
were determined by sequence analysis. As the 3' EcoRI/Notl frag-
ment comigrated with the vector, a triple digestion with Dral which
digests the vector and the 3' noncoding region of the DNA was
performed, and the2.6-kb EcoRI-Dral fragment was cloned into
the 5' CDM8 construction afterdigestion with EcoRl and Notl.
Partial sequence analysis confirmed that construction was as pre-
dicted. Cos-I cells were transfected as described (27). Transfection
efficiency was 10-30% as assessedby immunofluorescence andFACS
analysis with arabbit anti-human mannosereceptor antisera (a gift
of Dr. P. Stahl, Washington University, St. Louis, MO). A tailless
mutant wasprepared by constructing an antisense primer from 4,276
to 4,308 by containing an Hpa I site and including the first two
aminoacidsof thecytoplasmic tail. The senseprimer was prepared
from 3,400by encompassing the Nsil site to 3,510bp. Theprimers
were annealed to full-length cloned MR DNA and a 812-bp frag-
ment was amplifiedusing thepolymerase chainreaction. Thefull-
length cDNA, MR CD8M8, wasthen digested with Nsil andHpal
which released a fragment from the Nsil site in the cDNA to a
unique flanking Hpal site, thereby removing the cytoplasmic tail
and some vector sequence. This was replaced with the812-bp PCR
product, thereby creating a clone confirmed by sequence analysis
that containedthe entire ectodomain, the transmembrane region,
and twolysines ofthecytoplasmic tail. This DNA wastransfected
into Cos-I cells as described above and the surface expression was
verified by immunofluorescenceandFACS analysis.TheFACS anal-
ysis was performed on 105 cells that were specifically stained with
a rabbit anti-human mannose receptor antisera (gift from Dr. P.
Stahl) and a FITC-conjugated goat and anti-rabbit second anti-
body (FisherScientific Co., Pittsburgh, PA). Mock-transfected Cos
cells represented controls for these experiments.
Uptake of'2sl-Mannose-BSA.
￿
Mannose-BSA (EY Laboratories,
San Mateo, CA) was radiolabeled as described (28) and uptake of
radiolabeled ligand was performedon Cos-I cells transfected with
MR CDM8 full-length clone. Cos-I cells transfected with CD64
served as controls and thioglycollate elicited mouseperitoneal mac-
rophages served as a positive control (28).
Phagocytosis Assays.
￿
MR CDM8-transfected Cos-I cells and
CD64-transfected Cos-Icellswere trypsinized for 24 h aftertrans-
fection and replated on glass coverslips in 24-well tissue culture
traysandcultivated forafurther 2din Dulbecco's modified medium
supplemented with 5% FCS. Thecells were then incubatedwith
Candidaalbicans strain 9177 (gift ofDr. D. Bonner, Squibb Medical
Institute, Princeton, NJ) for 5 and 20 min, respectively, at 37°C.
Thereafter the cells were washed several times in HBSS plus 1%FCS and either wet mounted for Nomarski (differential interfer-
ence contrast) microscopy or fixed with 1% formaldehyde and
viewed by phase-contrast microscopy. For electron microscopy, trans-
fected cells were cultivated on glasscoverslips or in 100-mm tissue
culture dishes and incubated with Candida albicans as describedabove,
for 5 or 20 min at 37°C. As the cells that had ingested yeasts ap-
peared to be less adherent than the nonphagocytic nontransfected
cells, the mediawere aspirated and the remaining cells were treated
with trypsin and then pelleted with the cells in the aspirate. There-
after the cell pellet was fixed in 2% glutaraldehyde in cacodylate
buffer, pH 7.4, and 500-nm sections were cut and stained with
toluidine blue, which stains the yeasts and the nucleus blue and
viewed by light microscopy, or uranyl acetate and lead citrate-stained
sections were examined by transmission electron microscopy as de-
scribed (29). Quantitation of phagocytosis was undertaken by ex-
amining fixed whole mount preparations of cells after they had
been incubated for 20 min at 37°C with a ratio of 20:1 Candida
albicans/cells. The preparation was stained with toluidine blue and
ingested yeasts were scored by Nomarski microscopy. Cells trans-
fected with the full-length MR cDNA particles that bound, but
were not ingested, scored negatively. Positive cells were graded as
those having <5 or >5 ingested particles. At least 100 cells were
counted in three independent coverslips. For cells transfected with
the tail minus construct, no particles were ingested and hence
binding of yeasts to the cells was viewed as positive and graded
as <5 or >5.
RNA Analysis.
￿
RNA was prepared from human alveolar mac-
rophages (gift of Dr. R. Rose, Harvard Medical School), human
umbilical vein endothelial cells, Hela cells, and HepG2 cells as de-
scribed. The RNA was size fractionated on an agarose gel and trans-
ferred to Nytran hybond membrane (Amersham Corp., Arlington
Heights, IL) and hybridized with a radiolabeled MR cDNA and
cl)NA for phosphoglycerate kinase (PGK) (30).
Results
Characteristics of the Macrophage Mannose Receptor
Partial cDNAs obtained from a human placental cDNA
library were used as probes to screen a macrophage cDNA
library as it was not certain, although likely, that the cell
that expressed the mannose receptor in placenta was a mac-
rophage. Analysis of overlapping cDNAs that represent
the human macrophage receptor (EMBL accession number
X55635) reveal that the macrophage-derived clones are iden-
tical to those from placenta (21) except for a C to T poly-
morphism at nucleotide 2284 that does not alter the encoded
amino acid Thr.
The features of the receptor are depicted in a schematic
diagram (Fig. 1 a) and include (a) a typical hydrophobic signal
peptide; (b) a cysteine-rich N112-terminal region; (c) a fibro-
nectin type II-like domain; (d) eight carbohydrate recognition-
like domains; (e) a hydrophobic transmembrane region; and
(f) a cytoplasmic tail.
Domain 1 Cysteine-rich NH2 Terminals. This region is
comprised of 147 amino acids and contains six cysteines. It
bears no homology to any other known structure, although
a cysteine-rich region has been described in the unpublished
COOH-terminal end of the type I macrophage scavenger
receptor (31), which has the opposite orientation to the man-
1787
￿
Ezekowitz et al.
nose receptor. The function of this region in the mannose
receptor is not known.
Domain 2 Fibronectin Type II Domain.
￿
The next region
between amino acids 139 and 192 resembles the type II re-
peat of fibronectin with identity at 26 out of 62 amino acids
(32). Although the precise function of this region is not
known, it is likely that it may play a role in interaction with
the extracellular matrix and may contribute to the spreading
and adhesion of tissue macrophages that express the man-
nose receptor.
The Carbohydrate Recognition-like Domains.
￿
The remainder
of the extracellular regions of the receptor are comprised of
eight segments which are related to the C-type carbohydrate
recognition domains (CRDs) ofanimal lectins (15). The pro-
totype of this ever growing family of nctin-like receptors is
the mammalian asialoglycoprotein receptors, which mediate
endocytosis of glycoproteins. However, these receptor-related
proteins are type II membrane proteins, have opposite orien-
tation to the mannose receptor and a single CRD, and are
not known to be phagocytic receptors.
A detailed analysis of the sequences of the CRDs of the
mannose receptor is shown in Fig. 1 b. The domains are aligned
with the positions of the "invariant" residues of the C-type
lectins. The repeats are grouped to emphasize the identity
of conserved amino acids and includes short intervening
stretches of amino acids that are not homologous to one an-
other. Domains 4 and 5 are the most homologous to one
another with 34% identity and 49% similarity. Both of these
domains have a characteristic WND motif, which is a fea-
ture of all other C-type lectins. These two domains bear the
closest homology to other known mannose-binding proteins
as shown in Fig. 1 C. The alignment of the COOH-terminal
62 amino acids of the mouse MBP-A and C, rat MBP-A and
C (Sastry, K., K. Zahedi, J.-M. Lemas, A.S. Whitehead, and
R.A.B. Ezekowitz, manuscript submitted for publication),
and human MBP (11, 24, 33) is shown with domains 4 and
5 of the mannose receptor. 32 of 62 amino acids from do-
mains 4 and 5 of the receptor are identical to at least one
of the mannose-binding proteins (Fig. 1 C) .
Cytoplasmic Domain.
￿
The COOH-terminal hydrophilic
cytoplasmic domain of the mannose receptor is of great in-
terest, especially since transfection of the receptor alone in
Cos-I cells is sufficient to mediate pinocytosis and more sur-
prisingly phagocytosis (see below). The localization of cer-
tain endocytic receptors to coated pits appears to be depen-
dent upon the motif FXNPXY (34). The mannose receptor
has a motifFXNTXY in the cytoplasmic tail positions 1406
to 1411, and it is of note that the proline, which appears to
be essential for LDL receptor localization to coated pits, is
replaced by a threonine in the mannose receptor. Noteworthy
in the analysis of the rest of this sequence is that it reveals
no other obvious homology to the cytoplasmic domains of
other endocytic receptors; however, there are several serines
and threonines that may be possible sites of phosphorylation.
RNA Analysis
Total RNA was isolated from a limited number of cell types
and analyzed by Northern analysis for mannose receptor tran-Figure 1 .
￿
(A) Proposed structural domains ofthemacrophagemannose receptor. The nucleotide sequence can be obtained viaEMBL accession number
X55635 and in reference 21 . (B) Alignment of eight carbohydrate recognition-like domains with each other with reference to the invariant residues
of C-type lectins (15) . Not all the "invariant" residues are conserved in each repeat and amino acids present in at least four of eight repeats are shown
below as common. Domains 4 and 5 are the most homologous to one another with34% identity and49% similarity. (C) Alignment ofcarbohydrate
recognition-like domains 4 and 5 with the COOH-terminal (64 amino acids of the carbohydrate recognition-like domains ofMBP from rat, mouse,
and human . Amino acids common to one or both mannose receptor carbohydrate recognition-like domains (MR CRD) 4 and 5 that are represented
in at least one of the five MBP sequences are boxed and highlighted below.
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alveolar macrophages, but not in RNA from human umbil-
ical vein endothelial cells, HeLa or HepG2 cells (Fig. 2) . In
addition, no detectable transcripts were observed in RNA
isolated in freshly isolated human monocytes or human my-
elomonocytic cell lines U937, HL60, or THP cells, all of
which do not express mannose receptor activity (results not
shown) . Southern blot analysis of human genomic DNA
digested with different restriction enzymes revealed that a
full-length MR cDNA hybridized to a limited number of
fragments (not shown) . The relatively simple hybridization
pattern suggests that a single gene encodes the mannose
receptor.
Mannose Receptor Expression and Endocytosis
Glycoconjugates prepared by derivatizing BSA with man-
nose have proven to be invaluable as high-affinity ligands for
a variety of receptors, including the mannose receptor, par-
ticularly when the molar ratio of sugar to protein is 20>1
(35) . As 1251-mannose-BSA has been used to quantify recep-
tor number and activity on macrophages isolated from ro-
dents and humans, we used this glycoconjugate to assess
receptor activity on populations ofCos-I cells that had been
transfected withMR CDM8, an expression vector containing
the full-length mannose receptor or Cos-I cells transfected
with the high affinity Fc receptor CD64 to serve as a con-
trol . The transfection efficiency varied between 10 and 30%
of cells as assessed by FACS analysis (Fig. 3 A) and im-
munofluorescence (not shown) . Fig . 3 B shows mannose-
specific uptake occurred only in the Cos-I cells transfected
with the mannose receptor and not in cells transfected with
CD64 . The uptake ofthe radiolabeled ligand was specifically
prevented by the mannose-rich yeast mannan which serves
as a competitive inhibitor.
Mannose Receptor Phagocytosis
The predominant physiological role of the mannose receptor
on tissue macrophages is the engagement microorganisms
that have mannose-rich cell walls. Candida albicans are examples
of such microorganisms and were used to assess whether the
mannose receptor alonewas sufficient to mediate binding and
uptake of these microorganisms in the absence of other mac-
rophage receptors in heterologous cells. Populations of Cos-I
cells transfected with MR CDM8 or the control plasmid
CD64 CDM8 expressed the surface receptor as determined
by the typical pattern ofmembrane staining and by FACS
analysis . Candida albicans were incubated with populations
containing MR' Cos-I cells for 5 or 20 min at 37°C. MR+
Cos-I cells had many adherent yeasts at 5 min and formed
membrane extensions around the particles (Fig . 3 c), which
are reminiscent of the early phagocytic events observed in
macrophages (36) . After 20 min ofincubation the yeasts had
been internalized by the mannose receptor-transfected Cos
cells, as evidenced by the presence of yeast within a phago-
cytic vacuole (Fig. 3D) . To quantitate the phagocytosis, trans-
fected Cos cells were incubated with Candida albicans for 20
min at37°C. Thereafter cell monolayers werefixed and stained
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Figure 2 .
￿
Northern blot analysis ofmacrophage mannose receptor. Total
RNA from human alveolar macrophages, HepG2 cells, Hela cells, and
human umbilical vein endothelial cells was size fractionated on an agarose
gel and transferred to a nylon membrane and hybridized with radiolabeled
cDNA representing the mannose receptor and a phosphoglycerate kinase
cDNA as a control (1.7-kb transcript present in all cells) (30) . Mannose
receptor transcripts of5.2 kb were observed only in human alveolar mac-
rophages as expected.
into toluidine blue, which stains yeasts and nuclei . 100 cells
from three independent coverslips were scored by Nomarski
microscopy. 10% of the cells had internalized 1-5 yeast par-
ticles and 7% internalized >5 . The cells that had ingested
many particles became less adherent, and in thisway are similar
to post-phagocytic macrophages. It also appeared that some
of the ingested yeasts were degraded and had begun to coa-
lesce, as seen on this unstained Nomarski light photomicro-
graph (Fig . 3 e) . It is likely, although not formally proven
by these studies, that these events are occurring in phagolyso-
somes . Mock-transfected Cos-I cells did not bind or ingest
yeast (Fig . 3f), nor did CD64-transfected cells (not shown) .
Tail Minus Receptor Is Internalization Defective
We surmised that the signal for phagocytosis most likely
resides in the 45 amino acids that comprise the cytoplasmic
tail . To test this hypothesiswe constructed a mutant receptor
that had all but two lysines of the cytoplasmic tail deleted.
15-20% of the transfected Cos-I cells expressed the mutant
receptor on the cell surface as detected by FACS analysis (Fig.
4A) . The level of expression of the mutant receptor on the
cell surface appeared comparable to the surface expression of
the entire receptor (compare Fig . 4A to Fig. 3A) . The anal-
yses oftails plus and tails minus populations were performed
as part of the same experiment in which identical reagents
and machine parameters were used . Cell populations trans-
fected with the tail minus receptor had greatly reduced up-
take of radiolabeled mannose-BSA that was almost entirely
mannan inhibitable (Fig. 4 B) .
We next incubated the tail minus transfected cells with
yeasts for up to 45 min at 37°C. The particles bound to the
cells, as shown by electron microscopy (Fig. 4 C), and did
not appear to form membrane extensions around the yeast
observed in the cells expressing the entire receptor (Fig. 3
C) . Light microscopy was performed on 500-nm sections,
in which hundreds of cells can be easily examined that werestained with toluidine blue, which clearly stains the yeasts.
Only bound, but not internalized particles were observed (Fig.
4 D), thereby supporting the contention that the receptor
tail is essential for endocytosis. Quantitation analysis similar
to that described for the tail plus transfectants was performed
by scoring cells that had specifically bound yeasts . This was
done on whole mount preparations stained with toluidine
blue and viewed by Nomarski light microscopy in order to
distinguish bound versus internal particles. No internal yeasts
were observed; however, 11% of the cells bound 1-5 yeasts
and 6% bound >5 . An example of a cell that bound many
yeasts isshown in Fig. 4E. The cells expressing the tail minus
receptors formed rosettes ofmany bound yeasts, which when
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Figure 3 .
￿
Mannose receptor expres-
sion and endocytosis in transfected Cos-I
cells. (A) FRCS analysis of transfected
Cos cells stained with a rabbit anti-
human mannose receptor antisen (solid
line) . Relative cell number was 10,000
cells, ofwhich 20% were positive. The
control represents an equal number of
mock-transfected cells. The experiment
represents three independent experi-
ments . (B) 8 x 105MR cDNA-trans-
fected Cos-I cells or CD64-transfected
Cos-I control cells wereincubated with
12SI-mannose-BSA (specific activity
2 x 1116 cpm/pg) in the presence or
absenceof1.25 mg/ml ofyeast mannan
for 20 min at 37°C . Results are a mean
± SD of quadruplicates and are repre-
sentative of two independent experi-
ments. (C) Electron micrograph of a
phagosome forming around a yeast that
had been incubated for 5 min at 37°C .
(D) Electron micrograph of a yeast
within a phagocytic vacuole after 20min
ofincubation at 37°C . (E) Light micro-
graph of 500-nm section showing a
yeast within a vacuole as well as some
boundyeast and an occasional free par-
ticle . Sections were stained with tolu-
idine blue, which stains the yeast and
the cell nuclei . (F) A Nomarski pho-
tomicrograph of a binucleate cell in
which numerous yeasts are seen in the
perinuclear region, many ofwhich have
lost their typical morphology and there-
fore appear to be degraded. The incu-
bation period was 20 min at 37°C.
viewed by Nomarski optics appeared adherent, but not in-
ternal to the cell (Fig. 4 E) . No specific binding was observed
in mock transfected cells (Fig . 4 F), although the occasional
adherent yeast was seen .
Discussion
Recognition and ingestion of microorganisms are hallmarks
of the macrophage as an effector cell in host defense. Macro-
phage receptors for different isotypes of Ig (FcR) (reviewed
in 37, 38) and third component of complement (CRI, CR3)
that mediate opsonin-dependent and -independent clearance
of pathogens have been well characterized (reviewed in 39,40) . Phagocyte lectin-like receptors that recognized specific
configurations ofcarbohydrates in target organisms have been
described (2, 41). The 170-kD mannose receptor, which is
expressed on tissue macrophages and not on circulatingphago-
cytes is able to engage complex ligands directly (reviewed in
reference 2) . The binding ofpathogenic microorganisms that
expresses high mannose glycans results in engulfment by the
macrophage as well as the release of an array of biologically
active mediators, which in large part regulate inflammatory
responses. In this study, we describe the structure ofthehuman
macrophage mannose receptor which is identical to thehuman
placental receptor (21) . Several structural features of the man-
nose receptor provide insights into its function as a phago-
cytic receptor.
1791
￿
Ezekowitz et al .
Figure 4 . Surface expression and
binding ofyeast to cells tranfected with
tail minus mutant receptor. Cos-1 were
transiently transfected with amannose
receptor construction that had all but
the first two amino acids of the cyto-
plasmic tail deleted . (A) FACS analysis
of transfected COW cells . The relative
cell number (10,000) andparameters of
analysis were identical to that described
in Fig . 3 A . The intensity of fluores-
cence and percent ofpositive cells were
very similar to those for the entire
receptor shown in Fig. 3 A . This ex-
periment is representative oftwo inde-
pendent experiments in which triplicate
samples were examined . (B) 5 x 105
MR tail minus andMR tail plus trans-
fected cells were incubated with 1251
mannose-BSA (0 .6 x 106 cpm/,ug) for
20 min at 37°C . Results are the mean
± SD oftriplicate samples and are rep-
resentative oftwo independent experi-
ments. Also shown is inhibition uptake
by 1.25 mg/ml of yeast mannan . (C)
Electron micrograph of yeast adherent
to a cell after incubation of 37°C for
45 min. (D) Nomarski photomicro-
graph of yeasts rosetting to, but not
being internalized by, MR tail minus
transfected cells despite incubation for
45 min at 37°C . (E) Light micrograph
of500-nmsection stained with toluidine
blue shows several yeasts bound but not
internalizedby the tail minus transfected
cells. (F) Nomarski photomicrograph
of mock-transfected Cos-1 cells in-
cubatedwith yeasts for 45 min at 37°C.
The yeasts are not specifically boundor
ingested .
Notable among the features of the mannose receptor's ec-
todomain is the presence of eight carbohydrate recognition-
like domains. The inclusion of each domain is based on the
presence of invariant residues that have been described for
C-type lectins, a family of soluble and extracellular matrix
and membrane proteins (15) that now includes the mannose
receptor. The mannose receptor is the only member of this
family that can mediate phagocytosis and the presence ofmul-
tiple CRDs may in part explain how this receptor recog-
nizes multivalent complex mannose glycans . Although the
relative contribution ofeach of the CRDs to ligand binding
and specificity is yet to be determined, inspection of the se-
quence provides some potential insights. In particular, do-
mains four and five are the most homologous to one another,with 34% identity and 49% similarity. In addition, they both
contain the motif WND which is invariant in all C-type
lectins. These two domains bear closest homology to the
MBPs, the proteins in this family that have the closest binding
specificity to the mannose receptor (42) . Comparison of the
mannose receptor CRDs 4 and 5 to five MBPs, two each
from rats (43) and mice (Sastry, K., K. Zahedi, J.-M. Lelas,
A. S. Whitehead, and R. A. B. Ezekowitz, manuscript sub-
mitted for publication) and one from human (11, 24, 33),
reveals that 32 amino acids out of 62 amino acids are repre-
sented in at least once in the last half of the CRDs of the
MBPs. Mutational analysis may allow some estimates of the
relative contributions of these conserved amino acids to ligand
binding specificity. The structural similarities between the
hepatocyte-derived soluble MBPs and the membrane man-
nose receptor in part explain their functional equivalence. The
mannose receptor is not expressed on circulating granulo-
cytes or monocytes, thereby conferring the ability to recog-
nize and clear circulating mannose-rich ligands on the hepa-
tocyte-derived MBP. Conversely, at uninflamed tissue sites
where mannose receptor-positive macrophages abound, the
MBP is absent, thereby conferring recognition of specific
mannose-rich pathogens to the mannose receptor.
The cysteine-rich NH2-terminal region bears no homol-
ogy to any other known sequence and its significance is not
known. It is possible that it may play a role in stabilizing
multimerization of receptors in the membrane, which would
then increase the valency and affinity of the mannose receptor.
Similarly, the function of the type II fibronectin-like repeat
is uncertain, but it may be important in the interaction of
tissue macrophages with the intracellular matrix, thereby
promoting adhesion and spreading at tissue sites.
Transient expression of the mannose receptor on the sur-
face of Cos-I cells results in uptake ofmannose rich glycocon-
jugates as expected. However, ability ofthese transfected cells
to bind and phagocytose yeast particles was surprising.
Receptor ligand interactions appeared to occur sequentially
around the full circumference of the target (Fig. 3 C) like
a zipper, with eventual fusion around the particle, consistent
with the model of phagocytosis proposed by Silverstein et
al. (36) . According to this scheme, local segments of plasma
membrane mediate binding ofthe particle, but ingestion results
from involvement of the cytoskeletal apparatus (36). The pre-
cise role of the contractile proteins in mannose receptor-de-
pendent phagocytosis in Cos-I cells has yet to be determined;
however, it would appear that the critical signal that mediates
phagocytosis resides in the 45 amino acids of the cytoplasmic
tail. Mutant receptors lacking the mannose receptor tail are
expressed on the cell surface, but are unable to ingest bound
particles. The absence of the receptor tail appears to inter-
rupt membrane flow around the particle (Fig. 4 c) and subse-
quent phagocytosis is impeded. These experiments imply that
ligation of the ectodomain of the mannose receptor by a mul-
tivalent ligand is able to signal phagocytosis and what ap-
pears to be correct routing to phagolysosomes even in a het-
erologous cell. Receptor-mediated endocytosis was also greatly
reduced by removal ofthe cytoplasmic tail, although still de-
tectable. The mannose receptor is distinct from other human
macrophage phagocyticreceptors, in particular, different iso-
forms of Fc receptors, which in macrophages are constitu-
tively phagocytic, yet when expressed in heterologous cells
mediates binding and not internalization of antibody-coated
erythrocytes (44, 45; Ezekowitz, R. A. B., unpublished). The
endocytic properties ofmouse macrophage Fc receptor FCRII-
B2 have been extensively studied (46) by transfection into
FcR - cells and these studies revealed that FcRlI-B2 was able
to accumulate in coated pits and mediate fluidphase pinocy-
tosis of bound ligand. Recent experiments have shown that
these FcRII-B2 Chinese hamster ovary cell transfectants
phagocytose opsonized heat-killed toxoplasma (47), thereby
providing an example of another macrophage phagocytic
receptor that is able to function in the heterologous cell. In-
spection of the 45 amino acids in the cytoplasmic tail of the
mannose receptor fails to reveal any obvious homology with
FcRlI-B2 isoform or with other receptors,except for the pres-
ence of the motif FXNTXY, which is almost identical to
the motif FXNPXY that appears to be required for localiza-
tion of certain receptors to coated pits (34). Although the
proline appears central for receptor localization to coated pits,
the mannose receptor does localize to coated pits and has a
threonine at this position. This difference implies that the
precise conservation of the motif is not essential or that in
the mannose receptor sequences other than this motifaccount
for its localization to coated pits. Clearly, a more detailed
analysis is necessary to determine which residues in the receptor
tail are critical for coated pit-dependent and -independent
endocytosis and phagocytosis. Open to question is whether
cells other than Cos-I cells can be induced to mediate man-
nose receptor-dependent phagocytosis, or whether this is a
feature of Cos cells that express accessary molecule(s) that
are required to complement the receptor in the phagocytic
event.
Mannose receptors on macrophages are responsible for the
signaling of the secretion of a number of potent inflamma-
tory mediators like arachidonate metabolites, reactive oxygen
intermediates, monokines, and neutral proteases. The mech-
anisms by which these receptors transmit transmembrane
signals have yet to be determined and the cytoplasmic do-
mains required for these functions remain to be determined.
Further studies are required to assess whether the mannose
receptor can signal secretion as well as phagocytosis in heter-
ologous cells or whether this triggering event is restricted
to macrophages.
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